| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 |
| Total Revenue | 570 | 1,238 | 918 | 645 |
| Cost of Revenue | 436 | 684 | 592 | 1,124 |
|
| Gross Profit | 134 | 553 | 326 | (479) |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
-
|
| Selling General and Administrative | 349 | 410 | 385 | (261) |
| Non Recurring |
-
|
-
|
-
|
-
|
| Others | 11 | 11 | 11 | 11 |
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss | (226) | 133 | (69) | (229) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | (1) | 6 | (1) | 27 |
| Earnings Before Interest And Taxes | (227) | 139 | (70) | (202) |
| Interest Expense | 32 | 32 | 32 | 31 |
| Income Before Tax | (259) | 108 | (102) | (232) |
| Income Tax Expense |
-
|
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | (259) | 108 | (102) | (232) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income | (259) | 108 | (102) | (232) |
| Preferred Stock And Other Adjustments |
-
| 18 | (18) |
-
|
|
| Net Income Applicable To Common Shares | ($259) | $126 | ($120) | ($232) |
0.51% Nasdaq 
Income Statement
